October 23, 2008
Wednesday November 12, 2008
8:00 am – 9:00 am (Continental Breakfast @ 7:30 am)
1.0 CLE credit now approved
Do consulting agreements with physicians result in the development or improvement of life saving products, or could they be kickback schemes rewarding high volume physicians for brand loyalty? Unlike drugs that usually are developed in company laboratories, medical devices frequently are created or improved by physicians. These physicians are involved in the design and development processes and are often hired to train colleagues in their use. As a result, many physicians may have a financial stake in the success of the device. Medical device manufactures frequently develop relationships with these physicians, as well as those who prescribe their products and act as opinion leaders within their field. Physicians may be compensated through royalty payments, consulting fees, speaking honorariums or subsidized trips to attend conferences and training sessions. Recently, the government has alleged that companies' payments are inducement to use the company's products, thereby making the payments illegal. How can you mitigate the likelihood of enforcement action while maintaining a competitive position in this very competitive industry?
Highlights that will be discussed by this panel include:
- Recent DOJ activities that have impacted the industry
- Increased compliance activities by medical device and pharmaceutical industry
- Handling conflict of interest in the academic setting
- Physician involvement with the industry and role of bias
- Value of physician input for the advancement of technology
For more information (including speaker bios) and to register, please see the seminar website
This seminar is sponsored by Exponent, Inc., Saul Ewing, LLP, and UCKIZ.